Table 1 Baseline characteristics of screened patients in the nine conducted point prevalence surveys
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
Period | Nov | Oct | Oct | Nov | Dec | June | June | June | Nov | Â |
Hospitalised patients, n | 626 | 653 | 655 | 613 | 597 | 664 | 583 | 559 | 544 | 5494 |
Patients screened, n (%) | 516 (82%) | 568 (87%) | 565 (86%) | 512 (84%) | 397 (69%) | 425 (64%) | 430 (74%) | 380 (68%) | 372 (68%) | 4165 (76%) |
Excluded cultures, n | 0 | 10 | 5 | 10 | 4 | 0 | 5 | 7 | 5 | 46 (1%) |
Evaluable cultures, n (%) | 516 (82%) | 558 (86%) | 560 (86%) | 502 (82%) | 393 (66%) | 425 (64%) | 425 (73%) | 373 (67%) | 367 (68%) | 4119 (75%) |
Age (years), median, (IQR) | 65,5 (50-75.8) | 66 (50–76) | 67 (47,3–76) | 67 (54–78) | 71 (58.5–80) | 68 (53–76) | 68 (56–78) | 71 (57–78) | 70 (58–78) | 68 (53–77) |
Length of stay (days), median, (IQR) | 2 (1–6) | 2 (0–6) | 2 (0–5) | 3.5 (1–8) | 4 (1–9) | 2 (0–7) | 3 (1-7.5) | 4 (1–8) | 3 (1–8) | 3 (1–7) |
Sex, n (%) female | 250 (48%) | 290 (52%) | 290 (52%) | 271 (54%) | 172 (44%) | 204 (48%) | 221 (52%) | 174 (47%) | 180 (49%) | 2052 (50%) |
Medical specialty, n (%) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Intensive care | 18 (4%) | 13 (2%) | 18 (3%) | 22 (4%) | 18 (5%) | 19 (5%) | 20 (5%) | 20 (5%) | 14 (4%) | 162 (4%) |
Internal medicine | 107 (21%) | 105 (20%) | 106 (19%) | 108 (22%) | 55 (14%) | 87 (21%) | 87 (21%) | 71 (19%) | 102 (28%) | 828 (20%) |
General surgery | 81 (16%) | 83 (15%) | 85 (15%) | 80 (16%) | 70 (18%) | 75 (18%) | 80 (19%) | 58 (16%) | 38 (10%) | 650 (16%) |
Other | 310 (60%) | 357 (64%) | 351 (63%) | 292 (59%) | 250 (64%) | 244 (57%) | 238 (56%) | 224 (60%) | 213 (58%) | 2479 (60%) |